Catalyst Wire Dossier Catalyst Wire Dossier

InductOs

bone morphogenetic protein-2 (rhBMP-2) · Pfizer
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for InductOs, covering 2009-09-07 to 2021-10-18. Get the full timeline:

Most recent: EMA Authorised: Inductos (dibotermin alfa) — Medtronic BioPharma B.V.

See pricing